Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Is there a role for pharmacoeconomics in developing countries?

Literature DB >> 21080732

Is there a role for pharmacoeconomics in developing countries?

Zaheer-Ud-Din Babar¹, Shane Scahill.

Abstract

Mesh：

Year: 2010 PMID： 21080732 DOI： 10.2165/11584890-000000000-00000

Source DB: PubMed Journal: Pharmacoeconomics ISSN： 1170-7690 Impact factor: 4.981

× No keyword cloud information.

9 in total

1. Pharmaceutical reform and physician strikes in Korea: separation of drug prescribing and dispensing.

Authors: Soonman Kwon
Journal: Soc Sci Med Date: 2003-08 Impact factor: 4.634

2. Impact of separating drug prescribing and dispensing on provider behaviour: Taiwan's experience.

Authors: Y J Chou; Winnie C Yip; Cheng-Hua Lee; Nicole Huang; Ying-Pei Sun; Hong-Jen Chang
Journal: Health Policy Plan Date: 2003-09 Impact factor: 3.344

3. Lessons from Korea's pharmaceutical policy reform: the separation of medical institutions and pharmacies for outpatient care.

Authors: Han Joong Kim; Woojin Chung; Sang Gyu Lee
Journal: Health Policy Date: 2004-06 Impact factor: 2.980

4. The role of health technology assessment on pharmaceutical reimbursement in selected middle-income countries.

Authors: Wija Oortwijn; Judith Mathijssen; David Banta
Journal: Health Policy Date: 2010-01-13 Impact factor: 2.980

5. Health technology assessment in South Korea.

Authors: Chang-yup Kim
Journal: Int J Technol Assess Health Care Date: 2009-06-16 Impact factor: 2.188

6. Developing nations special issue.

Authors: Mendel E Singer
Journal: Pharmacoeconomics Date: 2009 Impact factor: 4.981

7. The future of health technology assessment in healthcare decision making in Asia.

Authors: Bong-Min Yang
Journal: Pharmacoeconomics Date: 2009 Impact factor: 4.981

8. Cost effectiveness of facility-based care, home-based care and mobile clinics for provision of antiretroviral therapy in Uganda.

Authors: Joseph B Babigumira; Ajay K Sethi; Kathleen A Smyth; Mendel E Singer
Journal: Pharmacoeconomics Date: 2009 Impact factor: 4.981

9. Evaluating drug prices, availability, affordability, and price components: implications for access to drugs in Malaysia.

Authors: Zaheer Ud Din Babar; Mohamed Izham Mohamed Ibrahim; Harpal Singh; Nadeem Irfan Bukahri; Andrew Creese
Journal: PLoS Med Date: 2007-03-27 Impact factor: 11.069

9 in total

13 in total

Review 1. Rotavirus vaccine RIX4414 (Rotarix™): a pharmacoeconomic review of its use in the prevention of rotavirus gastroenteritis in developing countries.

Authors: Greg L Plosker
Journal: Pharmacoeconomics Date: 2011-11 Impact factor: 4.981

2. Is there a role for pharmacoeconomics in developing countries?

Authors: Asrul Akmal Shafie; Mohamed Azmi Hassali
Journal: Pharmacoeconomics Date: 2011-01 Impact factor: 4.981

3. Is there a role for pharmacoeconomics in developing countries?

Authors: Jonathan R Harper
Journal: Pharmacoeconomics Date: 2011-05 Impact factor: 4.981

4. Is there a role for pharmacoeconomics in developing countries?

Authors: Román Pérez Velasco; Yot Teerawattananon
Journal: Pharmacoeconomics Date: 2011-05 Impact factor: 4.981

5. Comparing cost-effectiveness results for a vaccine across different countries worldwide: what can we learn?

Authors: Baudouin Standaert; Olivier Ethgen; Rachel Emerson; Maarten Postma; Josephine Mauskopf
Journal: Adv Ther Date: 2014-10-21 Impact factor: 3.845

Review 6. Pharmacoeconomics and its implication on priority-setting for essential medicines in Tanzania: a systematic review.

Authors: Amani Thomas Mori; Bjarne Robberstad
Journal: BMC Med Inform Decis Mak Date: 2012-09-27 Impact factor: 2.796

Review 7. Pharmacoeconomic spotlight on rotavirus vaccine RIX4414 (Rotarix™) in the prevention of rotavirus gastroenteritis in developing countries.

Authors: Greg L Plosker
Journal: Paediatr Drugs Date: 2012-12-01 Impact factor: 3.930